Literature DB >> 4609344

Bioavailability of diphenylhydantoin.

K S Albert, E Sakmar, M R Hallmark, D J Weidler, J G Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4609344     DOI： 10.1002/cpt1974164727

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.

Authors:  J G Wagner; D A Ganes; K K Midha; I Gonzalez-Younes; J C Sackellares; L D Olson; M B Affrime; J E Patrick
Journal:  J Pharmacokinet Biopharm       Date:  1991-08

2.  Nonlinear assessment of phenytoin bioavailability.

Authors:  W J Jusko; J R Koup; G Alván
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

3.  Bioavailability of 11 phenytoin products.

Authors:  A P Melikian; A B Straughn; G W Slywka; P L Whyatt; M C Meyer
Journal:  J Pharmacokinet Biopharm       Date:  1977-04

4.  Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

Authors:  A Richens
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

5.  The bioavailability of phenytoin.

Authors:  R Gugler; W Fröscher; M Eichelbaum; G Hildenbrand
Journal:  J Neurol       Date:  1977-10-07       Impact factor: 4.849
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.